You are here
- Home
- Diseases & Conditions
- All Diseases and Conditions
Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male Patients
- Disease
- lung cancer
- Drug Name
- IRESSA
- Generic Name
- gefitinib
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- Non-Interventional Study
- Start Date
- Aug 24, 2009
- Study Name
- NIS-OTW-IRE-2009/1
- Study Id
- NIS-OTW-IRE-2009/1
- ClinicalTrials.gov ID
- NCT00922025
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report
-
Nov 29, 2011
- NIS-OTW-IRE-2009/1.pdf (92 KB)
